In an attempt to distance itself from the opioid epedemic, Purdue Pharma recently made some leadership changes to its board of directors and executive committee, as it battles hundreds of lawsuits across the United States for opioid-related deceptive sales and marketing practices that are the focus of U.S. enforcement authorities.
Purdue Pharma, maker of Oxycotin, is one of the most prominent legal targets of the opioid epidemic. So, it’s no wonder the company on July 24 named Steve Miller as chairman of the Purdue board of directors, as the company seeks to get clean. Author of the The Turnaround Kid: What I Learned Rescuing America’s Most Troubled Companies, Miller has been credited with leading many critical corporate turnarounds, including the rescue of Chrysler in 1981, helping autoparts maker Delphi through bankruptcy, and serving as chairman of insurer American International Group in the middle of its federal bailout.
